GenomOncologyGenomOncology announces participation in Biden Cancer Initiative’s OCTICGenomOncology is excited to be a part of the Biden Cancer Initiative’s Oncology Clinical Trial Information Commons (OCTIC), joining forces…Jun 6, 2019Jun 6, 2019